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Abstract
Background: Exposure to cigarette smoking during foetal and early postnatal life may have
implications for lung health. The aim of this study was to assess the possible effects of such
exposure in utero on lower respiratory disease in children up to two years of age.
Methods: A birth cohort of 4089 newborn infants was followed for two years using parental
questionnaires. When the infant was two months old the parents completed a questionnaire on
various lifestyle factors, including maternal smoking during pregnancy and after birth. At one and
two years of age information was obtained by questionnaire on symptoms of allergic and
respiratory diseases as well as on environmental exposures, particularly exposure to
environmental tobacco smoke (ETS). Adjustments were made for potential confounders.
Results:  When the mother had smoked during pregnancy but not after that, there was an
increased risk of recurrent wheezing up to two years' age, ORadj = 2.2, (95% CI 1.3 – 3.6). The
corresponding OR was 1.6, (95% CI 1.2 – 2.3) for reported exposure to ETS with or without
maternal smoking in utero. Maternal smoking during pregnancy but no exposure to ETS also
increased the risk of doctor's diagnosed asthma up to two years of age, ORadj = 2.1, (95% CI 1.2 –
3.7).
Conclusion: Exposure to maternal cigarette smoking in utero is a risk factor for recurrent
wheezing, as well as doctor's diagnosed asthma in children up to two yearsof age.
Background
Many children are exposed to tobacco smoking, both
before and after they are born. Maternal smoking during
pregnancy is believed to affect the utero-placental flow,
leading to an impaired foetal nutrition and consequent
intrauterine growth retardation [1]. The foetus of smoking
women is exposed from the time of conception to the
same levels of nicotine as active smokers [2]. Smoking
during pregnancy affects foetal lung development,
reflected in spirometric flow in the neonate, especially
when there is a family history of asthma and hypertension
during pregnancy [3,4] and causes abnormal airway func-
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tion [5,6]. Effects of ETS due to parental smoking on res-
piratory health in early childhood have been described in
epidemiological studies [7-10] but few have made an
effort to discriminate between effects of prenatal and post-
natal exposure. Recent studies, however, suggest that
smoke exposure in utero may be at least as detrimental to
respiratory health in early life as postnatal exposure to ETS
[11,12].
This prospective birth cohort study focuses on maternal
smoking during pregnancy as a risk factor for recurrent
wheezing during the first two years of life.
Methods
Study subjects
From February 1994 until November 1996, 4089 new-
born infants (2,024 girls and 2,065 boys) were included
in a population based prospective study, BAMSE (Chil-
dren, Allergy, Milieu, Stockholm, Epidemiological sur-
vey). The children were born in predefined areas in
Stockholm and recruited at their first visit to the Child
Health Centre. During the recruitment period 7,221
infants were born in the study area and of these 1,256
were excluded because the families planned to move
within a year, had insufficient knowledge of Swedish or
an already enrolled older sibling. Another reason for
exclusion was a serious disease in the neonate. For 477
infants correct addresses were not available. Thirteen hun-
dred and ninety-nine declined participation. The final
study cohort thus constituted 75 % of the eligible chil-
dren. Details of the study design, inclusion criteria, enrol-
ment and data collection are described in detail elsewhere
[13-15].
Questionnaire
The first questionnaire was filled in by the parents at the
time of enrolment (Q0) at a median age of the children of
2 months (10th percentile 0 months, 90th percentile 5
months of age). The questionnaire aimed to assess the
home environment as well as various indoor environmen-
tal exposures such as maternal smoking during pregnancy
and smoking habits of both parents after birth of the
child. A second part of the questionnaire covered the
health of both parents with focus on allergic diseases i.e.
asthma, allergic rhino-conjunctivitis and eczema. Socioe-
conomic status was classified according to the Nordic
standard occupational classification (NYK) and Swedish
socio-economic classification (SEI) [16]. The children
were categorised on the basis of their parents' occupation
into blue-collar workers, white-collar workers and others
(students, unemployed). Identical questionnaires (Q1
and Q2) dealt with disease symptoms in the children and
were distributed by mail to the parents when the children
were one and two years of age. Combinations of reported
symptoms were used to define criteria for different diag-
noses (see below). Information on important exposure
factors, such as parental smoking and breast-feeding, were
also obtained from the questionnaires. The questions on
symptoms and tobacco smoke exposure have been used
in earlier studies [17-19]. Reminders for all three ques-
tionnaires were sent three times. The response rates to Q1
and Q2 were 96% and 94%, respectively. The median age
for answering Q1 was 12 months and for Q2 24 months.
Those who had responded to all three questionnaires (N
= 3,791, 93%) before one, two and three years of age of
the child, respectively, constituted the basis for this study.
Assessment of pre- and postnatal tobacco smoke exposure
Foetal exposure to maternal smoking was reported in Q0
and was defined as maternal daily smoking of one ciga-
rette or more during any trimester of pregnancy. The
degree of such exposure was quantified for each trimester
separately. Information on paternal smoking during the
period in utero was not collected.
ETS was defined from exposure to maternal smoking of
one cigarette or more daily during the first months of life
and/or maternal smoking at one year of age of the child.
Quantitative information i.e. the number of cigarettes
smoked both of mothers and fathers, was obtained in Q0
for the first two months, Q1 and Q2 for the first and sec-
ond year of life, respectively. In Q0 the parents also indi-
cated whether they smoked at home and when the answer
was yes whether they smoked on the balcony/at an open
window/under the fan, thus actively avoiding direct expo-
sure of the child.
Classification of outcome
Recurrent wheezing up to two years of age
Three episodes of wheezing or more after three months of
age in combination with the use of inhaled glucocorti-
coids and/or signs of bronchial hyperreactivity (wheezing
or severe coughing when playing or being excited, or dis-
turbed coughing at night not associated with common
cold).
Doctor's diagnosed asthma
Reported "asthma" diagnosed by a doctor during the first
and/or second year of life of the child.
Any wheezing
Wheezing and/or disturbing cough at night not associated
with a common cold during the first and/or second year
of life.
Statistics
Odds ratios (ORs) and ninety-five percent confidence
intervals (CIs) were calculated using logistic regression. To
identify potential confounders several models including
various covariates were tested (heredity, socioeconomy,Respiratory Research 2006, 7:3 http://respiratory-research.com/content/7/1/3
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maternal age, keeping of cat and/or dog, construction year
of the home and duration of breastfeeding). Finally,
adjustments were made for heredity (defined as doctor-
diagnosed asthma and asthma medication and/or allergic
rhino-conjunctivitis diagnosed by a doctor in combina-
tion with reported allergy to furred pets and/or pollen in
one or both parents), exclusive breastfeeding during 4
months or more and maternal age ≥ 26 years, because
these variables changed the OR estimates for smoking
exposure. To test for interaction between smoking and
other covariates an interaction term was included in the
logistic regression model. The chi-square test and the
Fisher exact test were used for statistical analyses of pro-
portions.
Complete information on maternal smoking during preg-
nancy and answers on all three questionnaires were
required to be included in the analyses and this was avail-
able for 3790 subjects.
Statistical analyses were made with the Stata Statistical
Software: Release 8.0 (College Station, Texas, USA).
The study was approved by the ethical committee at the
Karolinska Institutet, Stockholm, Sweden.
Results
Short duration of breast-feeding, maternal age below 26
years, socio-economic status of the parents, the keeping of
cat and/or dog and reported dampness were all associated
with maternal smoking during pregnancy (table 1). In
total, 469 infants were exposed to maternal smoking in
utero. The prevalence of smoking decreased during preg-
nancy and reported smoking during the first, second and
third trimester were 12%, 10 % and 9 % respectively.
Twelve percent of the mothers reported to have smoked at
least one cigarette daily during any part of or all through
pregnancy. During the child's first two months the corre-
sponding proportion was 8.0%, and when the child was
one and two years old 9.4 and 10%, respectively. The cor-
responding reported postnatal exposure to paternal smok-
ing was 16, 12 and 11%, respectively. Any exposure to ETS
during the first two years of life of the children was
reported for 25% of the children. In families with smok-
ing fathers 34% of the mothers smoked compared to
8.3% in families with non-smoking fathers (p < 0.001).
Most of the smoking parents (94%) reported in Q0 that
they almost always smoked only outdoors, near open
window or under the fan when at home.
The reported smoking of mothers with asthma or respira-
tory allergy (asthma requiring medication and/or doctor's
diagnosed allergic rhino-conjunctivitis with reported
allergy to furred pets and/or pollen) tended to be lower
than that of mothers without such allergy both during
pregnancy and the child's first two years (figure 1). This
also held true for paternal smoking.
The cumulative incidence of recurrent wheezing, doctor's
diagnosed asthma and any wheezing up to two years of
age were 8.5%, 6.5% and 27%, respectively. The reported
smoking pattern of mothers of children with recurrent
wheezing differed from that of the mothers with children
without recurrent wheezing (figure 2). Maternal smoking
Table 1: Characteristics of a cohort of children and their families by exposure to maternal daily smoking of one cigarette or more 
during pregnancy
No foetal exposure Foetal exposure to tobacco smoking
n/N1 % 95% CI n/N1 % 95% CI p-value2
Gender (male) 1676/3321 51 49 – 52 242/469 52 47 – 56 0.646
Parental asthma 533/3302 16 15 – 17 73/457 16 13 – 19 0.927
Birth weight <2500 g 121/3321 3.6 3.0 – 4.3 19/469 4.1 2.5 – 6.3 0.661
Gestational age <36 w 102/3321 3.1 2.5 – 3.7 15/469 3.2 1.8 – 5.2 0.946
Exclusive breastfeeding ≥4 months 2690/3316 81 80 – 82 323/469 69 65 – 73 <0.001
Maternal age ≥26 years 3091/3320 93 92 – 94 413/469 88 85 – 95 <0.001
Socioeconomic index (SEI)3
1) Blue-collar 482/3311 15 13 – 16 140/468 30 26 – 34 <0.001
2) White collar 2792/3311 84 83 – 86 323/468 69 62 – 71 <0.001
3) Others4 37/3311 1.1 0.8 – 1.5 5/468 1.1 0.1 – 2.0 0.924
Keeping of cat and/or dog 426/3321 13 12 – 14 121/469 26 22 – 30 <0.001
Signs of dampness5 267/3309 8.1 7.1 – 9.0 39/468 8.3 5.8 – 11 0.844
Construction year of the home >1961 1679/3319 49 48 – 51 266/468 57 52 – 61 0.003
1 The numbers do not add up because of missing data.
2 Pearson chi-square test.
3 Socioeconomic status of the parents according to socioeconomic index measured by the Nordic standard occupational classification (NYK) and 
Swedish socioeconomic classification (SEI).
4 Student, unemployed etc.
5Smell or visible signs of mould in the dwelling and/or water damage inside construction.Respiratory Research 2006, 7:3 http://respiratory-research.com/content/7/1/3
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of one cigarette daily or more was reported for 16 % of the
children with recurrent wheezing at one year of age, com-
pared to 8.7% for healthy children (p < 0.001). The corre-
sponding proportions at two year's age were 17 and 9.4%
(p < 0.001). Eleven percent of the mothers of the children
with recurrent wheezing reported to have smoked ten cig-
arettes or more daily at one and 12% at two years age. The
corresponding figures were 6.3% and 7.0% for mothers
with healthy children.
A large majority of infants (85%) were reported neither to
have been exposed to maternal smoking during preg-
nancy, nor to any maternal smoking during the first two
months of life and/or at one year of age, and these consti-
tuted the reference group. One-hundred and thirty-three
children (3.6%) had been exposed in utero, but not after
being born. Eleven percent of the children were exposed
to ETS with or without maternal smoking in utero. Only
2.4% of the children were reported to have been exposed
exclusively to ETS.
Maternal smoking during any period of pregnancy, but
not after giving birth was associated with an increased risk
of recurrent wheezing at two years of age, (ORadj = 2.2,
95% CI 1.3–3.6), (table 2). The effect appeared most pro-
nounced when there was maternal smoking during the
first and/or second trimester, (ORadj = 2.5, 95 % CI 1.5–
4.0), but not thereafter in a separate analysis using the
entire material and adjusting for the effect of ETS (data
not shown).
Exposure to ETS alone or in combination with exposure in
utero tended to be associated with an increased risk of
recurrent wheezing (ORadj = 1.6, 95 % CI 1.2 – 2.3). The
risk estimates were similar in the different exposure
groups for doctor's diagnosed asthma and any wheezing
up to two years of age, respectively (table 2). These effects
were independent of gender of the infant (data not
shown).
Exposure to cigarette smoking during pregnancy and of
maternal smoking during the child's first year of life
increased the risk of recurrent wheezing as well as of doc-
tor's diagnosed asthma and any wheezing, respectively, at
one year of age, in a similar way as reported in table 2.
Reported paternal smoking during the child's first year of
life had no additional effect on any of the outcomes under
study (data not shown).
The results of dose-response analyses were not conclusive
i.e. neither confirmed nor excluded a trend, mainly due to
low numbers of subjects in the high exposure groups
(data not shown). Furthermore, there was no clear evi-
dence of interaction between smoking and heredity or
gender (data not shown).
Discussion
This study provides strong evidence that exposure in utero
to maternal smoking is important for development of
recurrent wheezing during the first two years of life, irre-
spective of exposure to ETS after birth. Similar results have
been published by others, but generally without separat-
ing the effects of exposure in utero exposure to ETS during
the first few years of life [20,21]. The study by Lux and
coworkers, however, clearly indicates that maternal smok-
ing restricted to pregnancy causes wheezing [11]. The
design of their study is similar to ours and allows for sep-
aration of the effects of different exposure periods but data
Proportion of maternal smoking of one or more cigarettes  daily during pregnancy and during the first two years of the  child among children with and without recurrent wheezing Figure 2
Proportion of maternal smoking of one or more cigarettes 
daily during pregnancy and during the first two years of the 
child among children with and without recurrent wheezing.
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about smoking during pregnancy were only obtained for
gestational weeks 30–32. In the present study information
about maternal smoking during pregnancy encompassed
the various trimesters in detail. Our data suggest an effect
with exposure particularly during early pregnancy. If so,
this is possibly a consequence of an effect on intra-uterine
growth [1].
An effect of maternal smoking on the foetus has also been
documented by several studies of pulmonary function in
neonates [4,6,22,23]. Most of these studies indicate ham-
pered expiratory flows as indices of a detrimental effect. In
a study by Hoo and co-workers prematurely born infants,
in average seven weeks, were investigated and maternal
smoking was associated with reduced pulmonary func-
tion [24]. The spirometric data in neonates only give indi-
rect evidence of a reduction in airway diameter. For
obvious reasons no direct studies of morphological conse-
quences of exposure to smoking in the neonate lung have
been carried out in healthy term babies. However, in chil-
dren with sudden infant death increased airway thickness
has been associated with maternal smoking of more than
20 cigarettes daily [25]. To which extent this effect stems
from exposure prior to or after birth is not clear.
In many studies the role of ETS, as a determinant of child-
hood asthma, has been investigated but in most of them
without due consideration of the separate influence of
maternal smoking during pregnancy [8,26]. In a meta-
analysis by Strachan and Cook a pooled risk estimate of
1.57 was found for lower respiratory illness in relation to
smoking by either parent [7]. The relative contributions of
pre- and postnatal smoking were not disentangled. In the
study by Lux, an OR of 1.3 was found for exposure to ETS
exclusively [11]. Possibly, the effect of exposure in utero
may be the more important which is also supported by
our data.
In Sweden exposure of children to tobacco smoking has
been reduced to levels which are low in an international
perspective. This is probably a consequence of a very
active health policy and an effective maternal and child
health care. During the study there was also a campaign
"Smokefree children" through the Child Health Centres
which reached almost all (99.5%) of the families when
the baby was new-born (Statistics from Child Health Cen-
tres, Stockholm County Council, 1995). The effects of ETS
are possibly diminished because of an overall awareness
of the detrimental effects of exposure. This is supported by
the finding that 94% of the parents reportedly never
exposed their children to ETS. Exposure of the foetus, on
the other hand, cannot be avoided by the pregnant moth-
ers who are active smokers.
Participation in the study is most likely to have been
affected by parental awareness of health hazards associ-
ated with cigarette smoking. Thus, smokers may to a
higher extent than non-smokers have chosen not to join
the study. A study of non- responders and actively
excluded families of the BAMSE study showed that these
parents smoked more than those included in the cohort
[15]. This would render the study base less representative
of the population, but in relation to tobacco smoke expo-
sure probably not affect the risk estimate of smoking
Table 2: Recurrent wheezing, doctor's diagnosed asthma and any wheezing up to two years of age in relation to exposure to maternal 
smoking during pregnancy6 and ETS7 with or without maternal smoking during pregnancy.
N n OR crude 95% CI OR adj8 95 % CI
Recurrent wheezing up to two years of age
No maternal smoking during pregnancy and no exposure to ETS9 3222 246 1 1
Maternal smoking during pregnancy but no exposure to ETS 135 21 2.2 1.4 – 3.6 2.2 1.3 – 3.6
Exposure to ETS with or without smoking during pregnancy 422 54 1.8 1.3 – 2.4 1.6 1.2 – 2.3
Doctor's diagnosed asthma up to two years of age
No maternal smoking during pregnancy and no exposure to ETS 3224 191 1 1
Maternal smoking during pregnancy but no exposure to ETS 134 16 2.2 1.3 – 3.7 2.1 1.2 – 3.7
Exposure to ETS with or without smoking during pregnancy 424 37 1.5 1.1 – 2.2 1.4 0.95 – 2.1
Any wheezing up to two years of age
No maternal smoking during pregnancy and no exposure to ETS 3207 855 1 1
Maternal smoking during pregnancy but no exposure to ETS 135 50 1.6 1.1 – 2.3 1.7 1.2 – 2.4
Exposure to ETS with or without smoking during pregnancy 422 142 1.4 1.1 – 1.7 1.3 1.0 – 1.6
6 Maternal smoking of one cigarette a day or more.
7 Maternal tobacco smoking during the first months of life and/or at one year of life.
8 Adjusted for heredity, defined as asthma and/or allergic rhino- conjunctivitis diagnosed by a doctor and in combination with reported allergy to 
furred pets and/or pollen in one or both parents (reported asthma medication was required for asthma diagnosis), maternal age and length of 
exclusive breast feeding.
9 Reference category: no maternal smoking during pregnancy and no exposure to ETS.Respiratory Research 2006, 7:3 http://respiratory-research.com/content/7/1/3
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related health effects. Furthermore, parents with allergic
diseases would possibly be more willing to join the origi-
nal cohort but we found no such selection. We had the
advantage of a large sample, allowing for the assessment
of effects of exposures in subgroups of infants. Yet, possi-
ble biases must be taken into account. Smoking tobacco
was found to be associated with a negative family history
of allergic disease. Furthermore, we based the risk estima-
tion on maternal smoking only, for obvious reasons
regarding smoking in pregnancy, but this may lead to
some misclassification of exposure postnatally. The effects
of the role of ETS will be studied more in detail in the
future follow up if the cohort.
The main implication of this study is that smoking cessa-
tion programmes need to be targeted on childbearing
ages. In maternal health care such efforts should focus not
only on those who are already pregnant, but also on
women who plan to conceive.
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